3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Central Nervous System Neoplasms
2
Thrombocytopenia
1
Squamous Intraepithelial Lesions
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Oligodendroglioma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Gliosarcoma
1
Glioblastoma
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Astrocytoma
1
Anus Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Anemia, Refractory
1
Interventions
Sunitinib
19
Everolimus
17
Bevacizumab
13
aldesleukin
11
Sorafenib
11
Interleukin-2
10
Cyclophosphamide
10
Axitinib
10
Nivolumab
9
fludarabine phosphate
7
fludarabine
7
pembrolizumab
5
Gemcitabine
5
temsirolimus
4
pazopanib
4
Ipilimumab
4
peginterferon alfa-2b
3
durvalumab
3
cabozantinib
3
Radiosurgery
3
Interferon-alpha
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Filgrastim
3
Erlotinib Hydrochloride
3
Cryosurgery
3
vandetanib
2
spartalizumab
2
perflutren
2
ixabepilone
2
chiron
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Kidney Neoplasms
×
DNA Methylation
×
Clear all
No trials found.